Targeted Radiopharmaceuticals Summit US
26
Jul
-
28
Jul
2022
When
Boston
Massachusetts
USA
Where

With two prostate cancer-focused approvals in the last year, RLT is finally getting the attention it deserves from investors, biotech, and the wider oncology field. Though still the 3rd line of exotic therapy, the ever-growing pipeline of therapeutics is set to deliver new life-saving therapeutics to patients with various unmet oncological needs.

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

26 - 28 Jul 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Chief Business Strategy Officer
Vice President, Head of Clinical Development Radiopharmaceuticals
Senior Director, Radiopharmacology
Director, CMC Product Development
Chief Medical Officer
Senior Analyst/Director of Research

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Invicro

Invicro was founded with a mission of improving the role and function of imaging in translational drug discovery and development.

Advancing Nuclear Medicine

Advancing Nuclear Medicine cares for the well-being of people worldwide. Especially for their health. We believe everybody should have access to advanced treatments.

CHELATEC

Chelatec is a client oriented Contract Research Organization (CRO) specializing in radioactive labelling and preclinical investigations.

Eckert & Ziegler Medical

The Eckert & Ziegler Medical segment pools multifaceted expertise from various areas to provide a comprehensive range of products and services for radiotherapy, brachytherapy, nuclear medicine and molecular imaging.

Eczacibasi-Monrol Nuclear Products

Eczacıbaşı-Monrol is an innovative, international supplier of radiopharmaceuticals for diagnosis and treatment in nuclear medicine.

Fusion Pharmaceuticals

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.

iMiGiNE - PMB

PMB-ALCEN has been designing and developing a cutting-edge automated system for the production of radiopharmaceuticals. These are essential in clinical medicine, especially in PET imaging.

Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.

MIM Software Inc.

MIM Software Inc. provides practical imaging solutions in the fields of Radiation Oncology, Radiology, Nuclear Medicine, Urology, Neuroimaging, and Cardiac Imaging.

Radiopharm Theranostics

Radiopharm Theranostics is developing a world-class platform of radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses.

SpectronRx

Spectron provides GMP, pharmaceutical grade Lu-177, Ac-225 and I-131 for various clinical applications. Spectron operates under a quality program that has been inspected by the FDA with approved drugs FDG, NaF and Ammonia.

Organizer

Get emails from us

Thank you
Oops! Something went wrong